Cite
HARVARD Citation
Taieb, J. et al. (n.d.). 723PFirst-line (1L) full dose (f) and modified (m) FOLFIRINOX and gemcitabine+nab-paclitaxel (GN) treatment (tx) for metastatic pancreatic adenocarcinoma (mPAC) patients (pts) in routine clinical practice across Europe. Annals of oncology. p. . [Online].